Prostate cancer patients given hope by new 'triple-whammy' drug

.

Prostate cancer patients given hope by new 'triple-whammy' drug

At the annual meeting of the American Association for Cancer Research in Chicago, Harvard University scientists presented the results of a trial of a new drug - galeterone - which has recorded early success in treatment of advanced stage prostate cancer.

According to the scientists, the small phase one trial, involving 49 patients, showed that galeterone is effective in tackling advanced prostate cancer in three different ways --- it can block the "receptor" proteins which respond to testosterone; bring down the number of receptors in tumours; and successfully target an enzyme that is connected with hormone pathways involved in prostate cancer.

Revealing that the `triple whammy' galeterone drug has chiefly been developed for the treatment of cancer which stops responding to hormone therapy, the scientists said that even though the early galeterone trial results have been promising, the trial has been carried out on only a small number of patients.

The scientists also said that a larger phase two trial to further test the effectiveness of the drug, as well as to fully investigate the treatment's safety and all possible side-effects, has been planned for later this year.

Nonetheless, welcoming the results of the phase one trial - while also acknowledging that the new galeterone drug is in its "infancy" and full results are still to published -, Prostate Cancer Charity's research head Dr Kate Holmes said: "This very early stage research, conducted among a small group of men, indicates that galeterone shows potential as a new treatment for men with advanced prostate cancer."


Latest News

Mobileye to be the Largest Israeli IPO in the U.S.
GoPro Fails to Hold On to Its Blockbuster Start
Alpha Natural Resources Plan to Cut Down 1,100  Jobs in Coal Mines
California Proposes Very Humble Rate Hikes for Obamacare in 2015
Patients receiving 'second choice' drugs due to supply deficiencies
NuvaRing makers warn women of side effects
Australian couple refuses to take their surrogate baby with Down syndrome
Depression and anxiety happen in teens due to insomnia
Sierra Leone declares state of emergency with Ebola outbreak
Increase of Sales Tax on Cigarettes Lowered Smoking Rate in Japan by 20%
Republican House Votes accuse US President Barack Obama of Impeachment
In a Peppy Second Quarter US economy Experiences a 4% Growth